hubXchange
hubXchange focuses on providing content, intelligence, and connections to the global life sciences community by hosting business Xchanges. Their events are aimed at senior decision-makers in the Pharma and Biotech sectors, facilitating collaboration and innovation through roundtable discussions.
- 1:1 matchmaking services
- Expertly-curated roundtable discussions
- Networking opportunities for C-suite executives
Locations
Competitors
Sachs Associates is a leading organiser of investment forums and events focused on the life sciences and biotechnology sectors.
Probatech is dedicated to sourcing and connecting innovative pharma companies and investors with unique opportunities in the biotech sector.
William Harvey Research Limited is a contract research organisation established in 1990, specialising in preclinical drug evaluation services for the Biotech and Pharmaceutical sectors.
Company Details
hubXchange is operated by Hub Xchange Limited and is a Active company incorporated on 7 April 2017 with the registered office located in London, Greater London. Hub Xchange Limited was registered 8 years ago.
Status
Active
Size
Micro
Directors
2
Age
8 years old
Employees
9
Turnover
Unreported
Total Assets
£320.23K
Cash in Bank
£222
Total Liabilities
-£149.57K
Teams
12
8
2
3
Founder & CEO • Joined Sep 2017
Director, Head Of Projects • Joined Aug 2018
Project Manager • Joined Jan 2022
Marketing Director • Joined Mar 2024
Project Director • Joined Mar 2023
Project Director • Joined Mar 2025
Head Of Projects • Joined Feb 2025
Director Of Partnerships • Joined Jun 2023
Project Director Oncology Therapeutics • Joined Jul 2019
Event Sales Consultant • Joined Sep 2022
Founder & CEO • Joined Sep 2017
Project Manager • Joined Jan 2022
Marketing Director • Joined Mar 2024
Project Director • Joined Mar 2023
Project Director • Joined Mar 2025
Head Of Projects • Joined Feb 2025
Director Of Partnerships • Joined Jun 2023
Project Leader • Joined Oct 2024
Marketing Director • Joined Mar 2024
Event Sales Consultant • Joined Sep 2022
Director, Head Of Projects • Joined Aug 2018
Project Director Oncology Therapeutics • Joined Jul 2019
Project Leader - Antibody Therapeutics / Nucleic Acid Therapeutics / Advanced Therapies • Joined Oct 2024
View 12 members